News Conference News TCT 2023 BIOSTEMI: Degradable-Polymer, Ultrathin-Strut DES Shows No Late Catch-up at 5 Years Caitlin E. Cox October 27, 2023
Presentation TCT 2023 TCT 276: Efficacy of the Orsiro stent in percutaneous coronary intervention for hemodialysis patients compared with other stent types. Presenter: TANINOBU NARUMI October 25, 2023
Presentation TCT 2023 TCT 185: Safety and Performance Registry for an All-Comers Subject Population with the Limus Eluting Orsiro Mission Stent System Within Daily Clinical Practice: Twelve-Month Results of the BIOFLOW-VIII Registry Presenter: Georg Nollert October 25, 2023
Presentation TCT 2023 TCT 518: Final 5-year report of the randomized BIONYX trial assessing Onyx versus Orsiro drug-eluting stents in all-comers Presenter: Eline Ploumen October 25, 2023
News Conference News TCT 2023 In ACS, Ticagrelor Only After < 1 Month DAPT Beats Continuing Aspirin: T-PASS Yael L. Maxwell October 25, 2023
Presentation TCT 2023 TCT 669: Impact of Acute Coronary Syndromes on Long-Term Clinical Outcomes After Percutaneous Coronary Intervention With the Biolimus-Coated BioFreedom Stent or Biodegradable Polymer Sirolimus-Eluting Orsiro Stent: From the SORT OUT IX Trial Presenter: Manijeh Noori October 24, 2023
News Conference News TCT 2020 Stent Polymer Face-off Calls Bioresorbable Coatings Into Question Shelley Wood October 17, 2020
News Conference News TCT 2020 Ticagrelor Monotherapy Following 3-Month DAPT Cuts Post-PCI Bleeding After STEMI Todd Neale October 14, 2020
Presentation TCT 2020 TCT 167: Comparison of Stent Expansion Between Xience and Orsiro Stents in Heavily Calcified Coronary Arteries in Cadaver Heart Presenter: Yu Sato October 14, 2020
Presentation TCT 2020 TCT 260: A Prospective Randomized Multicenter Study to Assess the Safety and Effectiveness of the Orsiro Sirolimus Eluting Stent in the Treatment of Subjects With up to Two De Novo Coronary Artery Lesions – BIOFLOW IV: 5 Year Clinical Results Presenter: Bernhard Witzenbichler October 14, 2020
News Conference News TCT 2019 Ultrathin-Strut Orsiro Stent as Good as BioMatrix: BIODEGRADE Michael O'Riordan September 30, 2019
Presentation TCT 2019 ORSIRO: An “Ultra-Thin Strut” Metallic DES With Bioresorbable Polymer Presenter: George Dangas September 28, 2019
Presentation TCT 2019 A Personal Perspective: Why I Choose Orsiro in STEMI Presenter: Juan Fernando Iglesias September 26, 2019
Presentation TCT 2019 First Experience With FDA-Approved Orsiro in the USA Presenter: Farouc Jaffer September 26, 2019
Presentation TCT 2019 TCT 43: A Prospective Randomized Multicenter Study to Assess the Safety and Effectiveness of the Orsiro Sirolimus Eluting Stent in the Treatment of Subjects with up to two de novo Coronary Artery Lesions – BIOFLOW IV: 4 Years Clinical Results Presenter: Bernhard Witzenbichler September 25, 2019
News Conference News TCT 2018 Resolute Onyx Fares Well Against Thin-Strut Orsiro Stent in BIONYX All-Comers Study Michael O'Riordan September 22, 2018
News Conference News TCT 2018 CORRECTION: Polymer-Free BioFreedom Stent Faces Off Against Orsiro Michael O'Riordan September 22, 2018
News Opinion Editor's Corner TCT 2018 TCT 2018, Day One: ‘Back to the Future’ With Stents, Stents, and More Stents Shelley Wood September 22, 2018